Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that 20 abstracts related to Dupixent® (dupilumab) and the investigational therapy itepekimab will be presented at the European Respiratory Society (ERS) Congress 2024, taking place from September 7 to 11 in Vienna, Austria.…
Viatris Inc. (NASDAQ: VTRS), a leading global healthcare company, today presented results from its Phase 2 study of cenerimod (ACT-333441) as a late-breaking abstract at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress, held from August 21-25,…
Elanco Animal Health Incorporated (NYSE: ELAN) has announced a significant expansion of its biologics manufacturing facility in Elwood, Kansas. The 25,000-square-foot expansion represents a $130 million investment that will be carried out through 2026, aimed at bolstering the company’s monoclonal…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced its commitment to supporting the global response to the mpox health emergency by providing diagnostic tests specifically developed for mpox, formerly known as monkeypox. The World Health Organization (WHO) declared mpox a Public…
AbbVie (NYSE: ABBV) has announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of prior therapy.…
UptimeHealth, a leader in healthcare technology solutions, is excited to announce a strategic partnership with Darby Dental Supply, a top dental distributor in the U.S. This collaboration introduces Darby Dispatch, a new tool designed to enhance operational efficiency and compliance…
Daiwa Health Development, Inc. Announces Webinar with Dr. Fred Pescatore on Clinical Applications of RBAC Daiwa Health Development, Inc. is thrilled to host an upcoming webinar featuring Dr. Fred Pescatore, a distinguished expert in integrative medicine. Scheduled for August 29,…
AmorSui, a cutting-edge personal protective equipment (PPE) brand committed to safeguarding both people and the planet, has announced a successful $3.5 million seed funding round. This investment will propel AmorSui’s mission to enhance sustainability, inclusivity, and affordability in the PPE…
Oggi, Agendia ha annunciato di aver ricevuto la certificazione dell’Unione Europea (UE) In vitro Diagnostic Medical Device Regulation (IVDR) per tre dei suoi prodotti: MammaPrint® FFPE Microarray, BluePrint® FFPE Microarray e i kit MammaPrint® e BluePrint® NGS. Questi prodotti sono…
Legend Biotech Corporation (NASDAQ: LEGN), a global leader in cell therapy, has announced its unaudited financial results and notable corporate developments for the second quarter of 2024. CEO Statement Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech, commented, “The…
Royalty Pharma today released its financial results for the second quarter of 2024 and announced an increase in its full-year guidance for Portfolio Receipts. We achieved double-digit growth in Portfolio Receipts during the second quarter of 2024, surpassing our quarterly…
Bayer announced today that the FINEARTS-HF trial met its primary endpoint by achieving a statistically significant reduction in the composite of cardiovascular death and total (first and recurrent) heart failure (HF) events, including hospitalizations for HF or urgent HF visits.…
